Showing results (111-120 of 120) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Molecular Pharmacology|August 23, 2000
Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human originH M Sarau, J L Mooney, D B Schmidt, et al.Journal of Medicinal Chemistry|June 6, 1997
Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide frameworkG A Giardina, H M Sarau, C Farina, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|October 29, 2000
SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lungD C Underwood, R R Osborn, S Bochnowicz, et al.The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthmaM C Chabot-Fletcher, D C Underwood, J J Breton, et al.The Journal of Pharmacology and Experimental Therapeutics|March 29, 2000
SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistenceD C Underwood, R R Osborn, C J Kotzer, et al.Genes and Immunity|October 26, 2007
Polymorphisms in the endothelin-1 (EDN1) are associated with asthma in two populationsG Zhu, K Carlsen, K-H Carlsen, et al.Journal of Medicinal Chemistry|March 26, 1999
Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412)G A Giardina, L F Raveglia, M Grugni, et al.The Journal of Pharmacology and Experimental Therapeutics|June 1, 1997
Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonistH M Sarau, D E Griswold, W Potts, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 7, 1999
In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activityH M Sarau, J J Foley, D B Schmidt, et al.Nature|September 28, 1999
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14R S Ames, H M Sarau, J K Chambers, et al.Pageof 12